Пиносол

Quick links to important sections

Пиносол

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Пиносол

Quick Facts

Property Description
Active ingredient Eucalypti Oleum, Guaiazulene, Menthae Piperitae Oleum, Pini Silvestris Etheroleum, Thymol, alpha-Tocopherol Acetate
Form Nasal Solution (Drops)
Pharmacological class Local Antiseptic and Anti-inflammatory Agent
Common use General support for the nasal mucosa
Origin Phytopreparation with derived and synthetic components

1. Defining Пиносол: A Topical Multicomponent Preparation

Пиносол is defined as a specialized multicomponent medicinal preparation designed for topical intranasal application, formulated as a nasal solution (drops). It is primarily classified as a local antiseptic and anti-inflammatory agent. This drug entity is differentiated by its complex, fixed-dose combination, which is intended to provide a synergistic action across its diverse components. The preparation is consistently positioned for use in managing non-severe inflammation of the nasal lining, setting it apart from agents intended for systemic absorption.

2. Composition and Origin: Essential Oils, Guaiazulene, and alpha-Tocopherol

The preparation is correctly described as a phytopreparation, containing a blend of essential oils alongside other derived substances suspended in a neutral oil base. Key active components include Pini Silvestris Etheroleum, Eucalypti Oleum, and Menthae Piperitae Oleum. Eucalypti Oleum, for example, is recognized for its traditional use in upper respiratory tract support.

This blend is strategically supplemented by Thymol, known for its mild antiseptic properties, and the synthetic derivative Guaiazulene, which offers specific anti-inflammatory characteristics. Furthermore, the inclusion of alpha-Tocopherol Acetate (Vitamin E) is significant, as its role in supporting the trophic function and integrity of the nasal mucosa has been subject to medical confirmation.

3. General Purpose and Localized Support

The overall purpose of Пиносол is to deliver concentrated localized support aimed at alleviating discomfort associated with nasal irritation and inflammation. The combined action of its diverse ingredients delivers two main general benefits: the essential oils and Thymol confer a mild local antimicrobial activity, while Guaiazulene and Vitamin E work synergistically to soothe and support the protection and regeneration of the irritated mucosal surface.

Regulatory References

  1. EMA herbal monograph on Eucalypti aetheroleum

What side effects are possible with Пиносол?

Possible side effects and safety information

The safety profile for this multicomponent preparation, as described in official regulatory documents, is focused primarily on local reactions and hypersensitivity to its constituents, which include various essential oils.

Safety Entity Officially Documented Information
Adverse Reaction Scope Localized irritation reactions and Hypersensitivity/Allergic reactions.
System-Organ Classes Immune System Disorders and Respiratory, Thoracic and Mediastinal Disorders.
Common Manifestations Local effects may include a burning sensation, itching, redness, or swelling of the nasal mucosa.
Frequency Classification Adverse reactions, such as allergic responses, are classified as Rare in the local regulatory-aligned prescribing information.
Serious Adverse Reactions No specific high-severity events are explicitly designated as Serious Adverse Reactions in the official regulatory documentation.

Safety-Related Restrictions and Limitations

The official labeling includes specific contraindications that formally restrict its use. A primary safety constraint is the presence of known hypersensitivity to any of the preparation’s components. Furthermore, the product is contraindicated for individuals with existing allergic rhinitis, which indicates a need to avoid use in patients with pre-existing allergic inflammation of the nasal lining.

Population-Specific Constraint

There is a formal contraindication regarding age. The preparation must not be used in the pediatric population of children under 2 years of age. No specific time- or duration-related safety patterns are explicitly documented by regulatory authorities regarding increased risk at treatment initiation or with long-term exposure. The regulatory text also generally notes that drug interactions are not described for this specific combination product.

This structure ensures the risk profile is understood based on documented local risks and formal constraints on use, as defined by government regulatory authorities.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The official regulatory documentation for Пиносол primarily addresses two distinct overdose scenarios: topical overuse and accidental oral ingestion.

Overdose from localized, intranasal overuse is officially documented as an increase in the frequency and intensity of local side effects, such as pronounced nasal dryness, itching, and a burning sensation in the nasal lining. Management for this scenario is limited to discontinuing the product.

The critical overdose risk is associated with the accidental oral ingestion of the oil-based solution containing essential oils. Following ingestion, clinical manifestations may include gastrointestinal distress, such as nausea and vomiting.


When Immediate Medical Help Is Required

Official regulatory guidance mandates that patients seek immediate medical attention for all confirmed or suspected cases of accidental oral ingestion, particularly if a large volume was consumed or if systemic symptoms develop. This action is critical, as no specific antidote is known for this multicomponent preparation. Management is restricted to symptomatic and supportive treatment.

Category Regulatory Statement on Action
Urgent action Seek immediate medical attention for accidental ingestion.
Treatment basis Management must be symptomatic and supportive.
High-risk group Children require urgent medical evaluation following any accidental ingestion due to heightened risk of toxicity.

Therapeutic Uses of Пиносол

What Пиносол Treats: Main Uses and Benefits

The therapeutic application of Пиносол is generally focused on providing localized support and easing symptomatic discomfort across conditions presenting with localized discomfort. Essential oil preparations, which include one of the preparation's main active components, are relevant for easing symptoms in coughs and colds. The medication is commonly used in conditions presenting with localized discomfort, helping to address symptoms that may appear suddenly or intensify over time.

This medication is commonly used to help manage symptoms associated with acute rhinitis, rhinopharyngitis, and the persistent symptoms of chronic atrophic rhinitis. It is applied in clinical settings that involve acute symptom patterns, offering symptomatic relief when symptoms become more noticeable.

“The goal is supporting relief that helps ease the overall symptom burden and may contribute to better daily comfort.”


Acute Inflammation and Congestion Relief

This domain covers the management of acute inflammatory states that present with pronounced symptoms like localized swelling, soreness, and mild-to-moderate congestion. The supportive relief provided helps patients cope more steadily with difficult episodes and contributes to easing the overall symptom load during periods of heightened cold manifestations. It is relevant when symptoms create noticeable physiological strain.


Chronic Mucosal Support

This cluster addresses conditions requiring supportive symptomatic care, notably the symptoms of chronic atrophic rhinitis (dry nose syndrome). The preparation is relevant for managing persistent nasal dryness and crusting. It is applied when symptoms create noticeable functional strain, assisting with maintaining functional stability and supporting general well-being during symptomatic phases.

Quick Fact: Symptom Support
Acute Helps ease congestion and soreness in acute cold episodes.
Chronic Applied for dryness and crusting in chronic nasal conditions.
Context Supports symptomatic relief associated with tissue irritation or periods following procedures.

Regulatory References

  1. European Medicines Agency Monograph on Peppermint Oil

Eligibility and Restrictions for Use

Who can and cannot use Пиносол?

This section details the eligibility and exclusion criteria for using the medicine, strictly based on official government regulatory information.


Eligibility and Exclusion Summary

Population Category Eligibility Status (Regulatory Basis)
Children under 2 years Contraindicated (Must not use)
Children 2 years and older Eligible for use
Adults Eligible for use
Patients with Hypersensitivity Contraindicated (To any component of the medicine)
Patients with Allergic Rhinitis Contraindicated (Must not use)
Pregnant or Lactating Individuals Use is possible as indicated

Official Eligibility and Contraindication Statements

Official regulatory documents establish clear restrictions regarding who can and cannot use the medicine. The drug is contraindicated and must not be used by children under 2 years of age. Furthermore, use is prohibited for any patient with allergic rhinitis or a known hypersensitivity to the drug or any of its constituent components. These exclusions define the populations for whom the medicine poses a risk as defined by health authorities.

Use is considered possible during both pregnancy and the period of lactation (breastfeeding) when indicated. Patients who have recently undergone surgical intervention in the nasal cavity are advised to use the product only as prescribed by a doctor, signifying a need for special consideration in this clinical context.

What should I know about interactions with other medicines?

The official regulatory profile for Пиносол (Pinosol) nasal solution is based on its function as a specialized topical intranasal preparation. The formulation, which includes essential oils, Guaiazulene, and alpha-Tocopherol Acetate, is designed for highly localized action, and systemic exposure of its components is considered negligible. This localized pharmacological profile directly determines the official stance on interactions, which is the documented absence of specific interaction data in the regulatory labels issued by national medicines authorities.

Due to the lack of evidence of clinically relevant systemic absorption, the official prescribing information does not contain specific co-administration restrictions related to systemic drug interactions. The interaction structure is officially defined by the following regulatory facts:

Interaction Category Regulatory Status
Contraindicated Combinations None are formally listed in official documents based on interaction risk.
Pharmacokinetic Interactions Data on metabolic (e.g., CYP-mediated) or transporter interactions are absent.
Pharmacodynamic Interactions No additive or synergistic effects with other medicinal products are documented.
Timing Restrictions No mandatory time-separation windows for administration are specified.
Food/Substance Interactions No formal interactions with food, alcohol, or supplements are documented.

The consistent regulatory statement across jurisdictions asserts that data on the interaction of Пиносол with other medicinal products are absent. Consequently, the prescribing information does not impose interaction-related prohibitions, restrictions, or population-specific cautions that would otherwise be required based on documented clinical risk.

Mechanism of Action

Sensory Neural Modulation and Perception

This core mechanistic domain involves the rapid activation (agonism) of the Transient Receptor Potential Melastatin 8 ( TRPM8) ion channel by the Menthol component on sensory neurons within the nasal mucosa. This signaling cascade initiates a physiological perception of cooling and subjective increased airflow, which results in the perception of increased nasal patency, independent of vascular tone alteration.

️ Local Anti-Inflammatory and Trophic Support

This domain focuses on the modulation of key inflammatory mediators and cellular protection. Active components like Guaiazulene and 1,8-cineole inhibit the synthesis and release of pro-inflammatory cytokines ( TNF-alpha, interleukins), thereby modulating the local inflammatory cascade. Concurrently, alpha-Tocopherol Acetate and other agents provide antioxidant activity by scavenging ROS, contributing to the stabilization of epithelial cell membrane integrity following ROS exposure.

Surface Antimicrobial Disruption

The lipophilic components, notably Thymol and various terpenes, exert a localized mechanism of membrane disruption against surface microbes. This structural compromise results in a localized antimicrobial surface effect, contributing to the management of the surface microbial population.

Dosage and Administration Information

Administration Scope and Principles

The usage of Пиносол is strictly defined by its formulation as a nasal solution (drops), which mandates its administration via the topical intranasal route. This localized administration approach governs the entire use protocol, restricting application exclusively to the mucosal surfaces of the nasal cavities.

The standard dosing pattern involves the measured instillation of a fixed number of drops into each nostril during a single dosing session. To maintain continuous local support, the required frequency is typically multi-daily, with administration generally repeated three to four times over a 24-hour period.

Procedural and Time Constraints

As a topical preparation, there are no specific official instructions linking its administration to mealtimes, and no dilution or reconstitution steps are specified. Administration is solely performed using a dropper or pipette, which ensures proper localized delivery.

Official duration of use follows distinct patterns. For self-limiting acute episodes, the product is intended for a short-term, time-bound course (e.g., 5 to 7 days). For the symptomatic management of persistent chronic conditions, guidelines permit application on an intermittent basis. Furthermore, principles define the applicable population through an age-specific restriction, mandating that the medicine only be administered to patients above a specified minimum age, such as two or three years. This procedural structure defines the standardized use of the medicine as established for multi-component preparations.

Recent Clinical Evidence

Research evidence / Overview of studies for Пиносол

Evidence for Use in Acute Nasal Symptoms

Research exploring the effects of essential oil components similar to those in Пиносол (such as eucalyptus oil/cineole) was evaluated in the context of conditions characterized by fluctuating or episodic manifestations, like the common cold. These studies often take the form of short-term Randomized Controlled Trials (RCTs), where the preparations were compared to an inactive substance or another treatment. The research has focused on time intervals typically lasting from seven to fourteen days, corresponding to the period where symptoms become more noticeable during acute viral illnesses.

Studies monitored outcomes related to physical discomfort and outcomes describing episodic or acute changes. Findings describe patterns observed in the studies related to how patients reported their experience and how symptoms changed in the observed populations during the short study period. A key point is that research data show patterns related to single essential oil components rather than the specific topical intranasal multicomponent composition found in this preparation. While this research provides context, it does not determine whether an individual using the full intranasal formulation will respond similarly. Furthermore, follow-up durations were limited, focusing on short-term symptom changes during the acute illness phase.

Evidence for Chronic Mucosal Support

The preparation was evaluated in research settings focused on persistent discomfort and long-term support for the lining of the nose. This includes conditions associated with chronic dryness and irritation, like chronic atrophic rhinitis. The research base here primarily includes observational studies and some smaller-scale RCTs that have explored essential oil preparations and the specific component alpha-Tocopherol (Vitamin E), which was studied for its role in tissue health.

Studies monitored patient-reported outcomes describing perceived discomfort, such as dryness and crusting scores. The research describes how symptoms changed in the observed populations over typical moderate-term periods of four to eight weeks. For this category, the sample sizes were modest in many trials, and the evidence quality varies across studies due to the use of heterogeneous preparations. Long-term effects are not fully established, as there is limited information for outcomes beyond eight weeks.

Frequently Asked Questions (FAQ)

Common questions about Пиносол (FAQ)


Q: Does Пиносол help with a stuffy nose or only a runny nose?

A: According to the official product information, the medicine's mechanism involves the active ingredient menthol, which creates a feeling of cooling in the nose. This sensory effect leads to a subjective perception of increased airflow. This feeling of improved patency (or less stuffiness) is noted to be separate from the product’s local support for nasal irritation and inflammation.


Q: Is Пиносол considered a natural remedy because of its essential oil components?

A: Official regulatory sources classify the product as a multicomponent medicinal phytopreparation. This means it is a blend that includes essential oils, but also other substances that are derived or synthetic. While essential oils are a key feature, the product is regulated as a formal medicine with a defined composition.


Q: Can children use Пиносол, and is there a specific version for them?

A: Official documentation states the medicine is eligible for use in children aged 2 years and older. It is formally contraindicated for children younger than two years. The regulatory information for the product only describes the nasal solution (drops) formulation, and no specific version for children is detailed.


Q: Are there any reported side effects related to using Пиносол long-term?

A: Official safety documentation focuses on localized reactions and hypersensitivity. Regulatory authorities have not explicitly described specific safety patterns or increased risks related to the use of the medicine over a long period. Therefore, no formal guidance exists regarding specific safety implications for long-term exposure.


Q: Does Пиносол have an expiration date after it has been opened?

A: The official regulatory information defines an overall shelf-life of three years, noted by the expiration date on the packaging. However, a separate, specific period for use-after-opening is not formally documented in the official prescribing information. The official information specifies that the medicine must be stored according to the specific temperature and light instructions to maintain quality.


Q: What type of nasal congestion is Пиносол generally used for?

A: The overall purpose of the medicine is to provide localized support to the lining of the nose. It is generally used to alleviate discomfort associated with nasal irritation and inflammation, specifically for the management of non-severe inflammation of the nasal lining. The product helps soothe the irritated mucosal surface.


Q: Is Пиносол available in different strengths or formulations (e.g., spray vs. drops)?

A: According to official quick facts and administration guidance, the preparation is described and regulated solely as a nasal solution (drops). No other forms, such as a nasal spray or alternative strengths, are specified in the official regulatory documentation.


Q: Are there different instructions for using the nasal drops versus the nasal spray version?

A: Official regulatory texts provide detailed instructions only for the administration of the nasal solution (drops). Since the drops are the sole formulation described in the official documents, no comparative instructions for a nasal spray version are provided.


Q: Are there any documented cases of severe allergic reactions to Пиносол ingredients?

A: Official safety information lists allergic reactions as a possible adverse effect, classified as Rare in the regulatory prescribing information. Furthermore, no specific high-severity events are explicitly designated as Serious Adverse Reactions in the official regulatory documentation.


Q: How quickly can I expect to notice any effect after using Пиносол?

A: The product's mechanism involves the menthol component, which causes the rapid activation of a sensory receptor in the nasal lining. This action initiates the subjective perception of cooling and feeling of increased airflow soon after application. However, an exact time frame for when an individual will notice the overall effects is not provided in official regulatory documents.


Q: Is the strong scent from Пиносол considered normal?

A: The formulation is a phytopreparation containing essential oils, such as eucalyptus and pine, alongside menthol. These components naturally contribute to the product's aroma and the cooling sensation felt upon application. The distinct scent is a direct result of the active ingredients and their defined composition.


Q: Does using Пиносол make you feel drowsy or affect your ability to drive?

A: Official regulatory information defines this medicine as a topical preparation with negligible systemic exposure. Because of its localized action, the official prescribing information does not list warnings regarding effects such as drowsiness or impairment of the ability to drive or operate machinery.


Q: Can I use Пиносол if I have been diagnosed with chronic rhinitis?

A: The medicine is formally contraindicated (must not be used) by patients with existing allergic rhinitis. While research has examined the preparation in the context of chronic irritation, use for other forms of chronic rhinitis is not explicitly prohibited in the eligibility criteria outlined in official regulatory documents.


Q: Does Пиносол help prevent future colds, or is it only for symptom relief?

A: Official documents define the overall purpose as delivering localized support aimed at alleviating discomfort associated with nasal irritation and inflammation. The product is used for symptom management, and preventative use for future colds is not documented in the official regulatory information.


Q: Is it possible to become dependent on using Пиносол?

A: The preparation is a topical medicine with a localized action and is associated with negligible systemic exposure. Because of this, the official safety profile does not mention issues of dependence, which are typically a concern with certain systemically absorbed agents.


Q: What is the purpose of the oil base in the Пиносол formulation?

A: The active components of the medicine are suspended in a neutral oil base, which is necessary for the formulation as a nasal solution (drops). This base facilitates its administration via the topical intranasal route, ensuring localized delivery and support to the mucosal surfaces.


Q: Is Пиносол recommended for use in dry indoor environments?

A: Research evidence has explored the preparation's use in settings focused on providing long-term support for the nasal lining. This research included conditions associated with chronic dryness and irritation of the nose.


Q: Why is the official use condition described as only for specific types of rhinitis?

A: The use condition is defined by a formal safety restriction: the product is strictly contraindicated (must not be used) for individuals with existing allergic rhinitis. This safety constraint, as defined by health authorities, is a key factor that limits the applicable use conditions to non-allergic types of nasal inflammation.


Q: Does the effect of Пиносол last all night?

A: Official regulatory guidance notes that the required frequency to maintain continuous local support is typically multi-daily, usually repeated three to four times over a 24-hour period. The specific duration of effect from a single dose, such as whether it lasts an entire night, is not explicitly defined in the official documentation.


Q: Can Пиносол be used for a stuffy nose caused by environmental irritants?

A: The medicine is indicated for alleviating discomfort associated with general nasal irritation and inflammation. However, it is formally contraindicated for use if the irritation is due to allergic rhinitis. The official documentation does not address use specifically for environmental irritants, but it formally restricts use in cases of allergic rhinitis.


Q: Does using Пиносол require any specific preparation, like blowing your nose first?

A: Official procedural instructions focus on the proper application method, which involves measured instillation using a dropper or pipette. No other specific preparatory steps, such as rinsing or blowing the nose beforehand, are officially specified in the regulatory guidelines for administration.


Q: Can individuals with nut allergies use Пиносол?

A: The primary safety restriction is a formal contraindication for patients with known hypersensitivity to any of the preparation’s components. Beyond this general warning, specific substance allergies, such as nut allergies, are not addressed in the official regulatory documentation.


Q: Is the concentration of essential oils in Пиносол regulated?

A: Yes, the product is officially defined as a specialized multicomponent medicinal preparation. Therefore, its entire formulation, including the concentration of the constituent essential oils, is subject to the quality and safety standards defined by the national medicines authorities.


Q: Why is it described that Пиносол works differently than decongestants?

A: The product is described as working differently because its mechanism, which causes a feeling of increased airflow, is independent of vascular tone alteration. Decongestants typically work by altering vascular tone (constricting blood vessels), which is not the primary way the menthol component in this medicine functions.

How should Пиносол be stored and disposed of?

Storage and Disposal Requirements

The official labeling for Пиносол nasal drops defines strict storage conditions to ensure the product's quality and stability.

Requirement Official Regulatory Condition
Temperature Store between 15 C and 25 C.
Protection Store in a dry place and protected from light.
Container Must be kept in the original packaging.
Child Safety Must be stored out of the sight and reach of children.
Shelf-Life Do not use after the stated three-year expiration date.

The product must not be stored outside of the 15 C to 25 C temperature range. Expired or unused medicine must be disposed of according to local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Пиносол found in:

A-Z Index: